World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   808 records for 235 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Titration Study of ABX-1431
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function
Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers
A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome
Heat therapy(agnikarma) in Tennis Elbow
Not recruitingYesNCT03230292
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
Recruitment statusMain IDPublic titleDate of registrationResults available
Not RecruitingEUCTR2016-002934-57-DE This is a study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in adult patients with chronic plaque psoriasis. 03/11/2016 
Study of AT-527 in Healthy and HCV-Infected Subjects
Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis.
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-000957-37-GR Study to test the efficacy and safety of Bimekizumab and Certolizumab Pegol in patients with active ankylosing spondylitis 13/09/2017 
AuthorisedEUCTR2017-000957-37-DE Study to test the efficacy and safety of Bimekizumab and Certolizumab Pegol in patients with active ankylosing spondylitis 14/07/2017 
An international study at different study sites providing a drug called cemdisiran (ALN-CC5) to patients with Atypical Hemolytic Uremic Syndrome by a subcutaneous injection 20/06/2017 
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history